Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diclofenac for Actinic Keratoses Metabolism
NCT01935531Phase 4Completed
- Sponsor
- Universitätsklinikum Regensburg
- Start
- Jun 2013
- Primary completion
- Jan 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diclofenac in actinic keratosis (AK), sponsored by Universitätsklinikum Regensburg. Started Jun 2013; status: completed.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01935531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935531.